Şunu aradınız:: hunter (İngilizce - Maltaca)

upper hunter or
upper hunter jew

hunter - hunter valley
hunter — hunter valley

upper hunter valley or
upper hunter valley jew

upper hunter river valley
upper hunter river valley

elaprase is used to treat patients with hunter syndrome.
elaprase jintuża biex jikkura l-pazjenti bis-sindrome ta' hunter.

it represents a source of income and contributes to the subsistence of the hunter.
tirrappreżenta sors ta’ dħul u tikkontribwixxi għall-għixien tal-kaċċatur.

it replaces the enzyme that is missing or defective in patients with hunter syndrome.
din tissostitwixxi l-enzima li hi nieqsa jew difettuża fil-pazjenti bis-sindrome ta' hunter.

jackie hunter (chair) (uk) ceo of oi pharma partners ltd.
jackie hunter (president) (uk) president ta' oi pharma partners ltd.

abnormal behaviour or disturbance of the general condition of the live animal reported by the hunter;
aġir anormali jew disturb tal-kondizzjoni ġenerali ta' l-annimal ħaj irrappurtat mill-kaċċatur;

patients with hunter syndrome do not produce an enzyme called iduronate-2-sulfatase.
pazjenti bis-sindrome ta' hunter ma jipproduċux enzima msejħa iduronate-2-sulfatase.

this means that because hunter syndrome is rare, it has not been possible to obtain complete information about elaprase.
dan ifisser li billi s-sindrome ta' hunter huwa wieħed rari, ma kienx possibbli li jinkiseb tagħrif sħiħ dwar elaprase.

2 jankovic j, hunter c, dolimbek bz, dolimbek gs, adler ch, brashear a, et al.
2 jankovic j, hunter c, dolimbek bz, dolimbek gs, adler ch, brashear a, et al.

hunter syndrome, which is also known as mucopolysaccharidosis ii, is a rare, inherited disease that primarily affects male patients.
is-sindrome ta' hunter, li huwa magħruf ukoll bħala mukopolisakkaridożi ii, huwa marda rari li tintiret li taffettwa primarjament lill-pazjenti rġiel.

requirements are specified as to secure that the seal and/or the hunter is sufficiently stable and that the target can be properly visualised.
huma speċifikati rekwiżiti biex jiġi żgurat li l-foka u/jew il-kaċċatur ikunu stabbli biżżejjed u li l-mira tkun tista’ tiġi viżwalizzata kif xieraq.

elaprase is indicated for the long-term treatment of patients with hunter syndrome (mucopolysaccharidosis ii, mps ii).
elaprase huwa indikat għat-trattament fuq tul ta’ żmien ta’ pazjenti bis-sindromu ta’ hunter (mucopolysaccharidosis ii, mps ii).

hunter syndrome is an x-linked disease caused by insufficient levels of the lysosomal enzyme iduronate-2-sulfatase.
is-sindromu hunter huwa marda tat-tip x-linked ikkaġunata minn livelli insuffiċjenti ta’ l-enzima liżożomali iduronate-2-sulfatase.

small numbers of wild game, unskinned or unplucked, and, in the case of small wild game, ineviscerated, supplied directly by the hunter to the consumer or to the retailer;
selvaġġina fi kwantitajiet zġħar, mhux imqaxxra jew imnittfa, u, fil-każ ta' selvaġġina żgħira, mhux imnaddfa, fornita direttament mill-kaċċatur lill-konsumatur jew lill-bejjiegħ bl-imnut;

the hunter (either inuit/indigenous hunter or licensed hunter for resource management purposes) – having a unique identification number;
il-kaċċatur (jew kaċċatur inuit/indiġenu jew kaċċatur liċenzjat għal skopijiet ta’ ġestjoni tar-riżorsi) għandu jkollu numru ta’ identifikazzjoni uniku;

elaprase is used as enzyme replacement therapy to treat hunter syndrome (mucopolysaccharidosis ii) when the level of iduronate-2-sulfatase in the body is lower than normal.
elaprase jintuża bħala terapija ta ’ sostituzzjoni ta ’ l- enzimi biex jitratta s- sindromu ta ’ hunter (mucopolysaccharidosis ii) meta l- livell ta ’ iduronate- 2- sulfatase fil- ġisem ikun iktar baxx mis- soltu.

due to the missing or defective iduronate-2-sulfatase enzyme in patients with hunter syndrome, glycosaminoglycans progressively accumulate in the cells, leading to cellular engorgement, organomegaly, tissue destruction, and organ system dysfunction.
minħabba l-enzima iduronate-2-sulfatase nieqsa jew difettuża f’pazjenti bis- sindromu hunter, il-glycoaminoglycans jakkumulaw progressivament fiċ-ċelloli, u jwasslu għal nefħa ċellolari, organomegalija, qerda tat-tessuti, u funzjoni ħażina tas-sistema ta’ l-organi.